Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.87

-2.3%

Dec 5 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who started this subject	5/5/2001 12:30:48 PM
From: tuck	of 52153

Op-Ed piece from GenomeWeb concerning the ongoing relevance -- or lack thereof -- of the NIH and NSF for biotech: genomeweb.com Also, an audio interview with analyst Mathew Geller, in which he maintains that the only fundamental negative for biotech is the swamped and leaderless FDA. He considers it only mildly negative because he expects the situation to change for the better in a few months: channels.on24.com Finally, because I didn't know where else to put it, a DoubleTwist article on the latest hot drug delivery techniques: doubletwist.com Ya know, it might be worth starting a thread on delivery companies. Opinions? Volunteers? If there is interest, I'll throw one together in a week, if no one else wants to do it. Right now, I've got to start packing for a trip to Red Rocks (near Vegas) for a week. Try not to crash the market too hard while I'm gone. Cheers, Tuck

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next